Genomic Health, Pfizer Collaborate on Prognostic Renal Carcinoma Test

Jan 07, 2008

This article has been updated from a previous version, which incorrectly described the test as predictive instead of prognostic.

NEW YORK (GenomeWeb News) - Genomic Health said today it will work with Pfizer to develop a genomic test to estimate the risk of post-surgery recurrence of a carcinoma.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

Closely Intertwined

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Little From Here and There

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

This Week in Science

In Science this week: in vitro generation of human reproductive cells, and more.

All the Arms for Hugging

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.

Main menu